ZIOPHARM Oncology Prices 14.3 Mln Shares Offering At $3.50/Shr

(RTTNews) - ZIOPHARM Oncology, Inc. (ZIOP) has priced its prior announced public offering of 14.3 million shares at $3.50 per share, and all the offered shares are being sold by ZIOPHARM. The offering may close on October 29, 2013.

J.P. Morgan Securities LLC is acting as sole book-running manager for the offering. JMP Securities LLC and Griffin Securities, Inc. are acting as co-managers. The underwriters were granted a 30-day option to buy up to an additional 2.15 million shares.

ZIOPHARM would use the net proceeds for the overall development of its drug candidates, including its synthetic biology candidates and small molecule candidates, and for general corporate and working capital purposes, the company added.